Dark

Check out our API

AMBS
AMARANTUS BIOSCIENCE HLDG
stock OTC

Inactive

May 6, 2025

0.000001USD-99.667%(-0.000299)1,500

Pre-market

Dec 31, 1969

0.00USD-100.000%(0.00)0

After-hours

Dec 31, 1969

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Oct 7, 2020

07:00AM EDT Todos Medical Enters into Exclusive COVID-19 Testing Supply GlobeNewswire Inc

Sep 25, 2020

07:39AM EDT Todos Medical Enters Into COVID-19 PCR Testing Implementation and GlobeNewswire Inc

Sep 22, 2020

09:00AM EDT Todos Medical Expands Existing Contract for COVID-19 PCR Testing GlobeNewswire Inc

Sep 18, 2020

10:04AM EDT -- Significant progress in establishing COVID-19 PCR-based diagnostic testing business in US -- 3CL Protease-based saliva test making progress in Israel -- 3CL Protease inhibitor NLC-001 dietary supplement added to commercial portfolio -- 2019 convertible note holders and institutional Q1/2020 convertible note holders sign temporary lock-up agreement GlobeNewswire Inc

Sep 17, 2020

09:33AM EDT -- NLC-001 is a proprietary blend of plant extracts administered orally as dietary supplement -- US FDA granted Certificate of Free Sale for NLC-001 on August 28, 2020 -- JV evaluating potential of NLC-001 to treat COVID-19 in clinical studies in Israel -- Todos evaluating commercialization options for NLC-001 Worldwide GlobeNewswire Inc

Sep 16, 2020

09:38AM EDT Todos Medical Expands Partnership with Care G.B. Plus for GlobeNewswire Inc

Sep 3, 2020

08:03AM EDT Todos Medical Announces August Sales of $1,190,000, Up 100% GlobeNewswire Inc

Aug 31, 2020

07:54AM EDT Todos Medical Announces $23,760,000 Contract for COVID-19 PCR GlobeNewswire Inc

Aug 25, 2020

08:52AM EDT Todos Medical Appoints Marsha Fontanive as VP of Sales and Chris GlobeNewswire Inc

Aug 24, 2020

07:09AM EDT Todos Medical Announces $1.2 Million Contract for COVID-19 PCR GlobeNewswire Inc

Aug 21, 2020

08:54AM EDT -- 6-month contract anticipates demand of 3,000 tests per day -- Todos has the right to supply up to 30,000 tests per day if demand increases for the lab GlobeNewswire Inc

Aug 17, 2020

07:38AM EDT -- Achieves analytical performance for detecting active 3C-protease in a rapid visual format -- Initiates multicenter clinical trial at Assuta Ashdod Hospital and Tel Aviv University in Israel -- Technology opens potential for self-administered tests at home, school, work and airports GlobeNewswire Inc

Aug 14, 2020

07:57AM EDT Todos Medical Acquires Distribution Rights to SARS-CoV-2 Rapid GlobeNewswire Inc

Aug 7, 2020

08:53AM EDT Todos Medical Announces July Sales of COVID-19 Tests GlobeNewswire Inc

Aug 6, 2020

07:22AM EDT -- Initial Investment of $275,000 followed by up to $10 Million commitment over 24-months GlobeNewswire Inc

Aug 4, 2020

08:59AM EDT Todos Medical Appoints Dr. Jorge Leon as Consulting Chief Medical GlobeNewswire Inc

Aug 3, 2020

07:02AM EDT -- Temasek Life Sciences Accelerator-backed PATHNOVA to Offer COVID-19 Testing Kits Supplied by Todos in Singapore and Southeast Asia GlobeNewswire Inc

Jul 27, 2020

08:05AM EDT -- Todos Appoints Mr. Andrew Blumenthal, RN as VP Business Development GlobeNewswire Inc

Jul 20, 2020

07:52AM EDT Todos Medical Expands Management Team and Advisory Board GlobeNewswire Inc

Jul 16, 2020

07:00AM EDT Todos Medical Announces ANVISA Authorization in Brazil for 3D Med GlobeNewswire Inc

Share